John A Latham Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John A Latham.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John A Latham. John A Latham is Chief Scientific Officer in ALDER BIOPHARMACEUTICALS INC ($ALDR).
Latest Insider Trading Transactions of John A Latham
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 14.00 | 160,000 | 2,240,000 | 160,000 | |
| Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Grant | A | 9.35 | 487 | 4,553 | 244,180 | 243.7 K to 244.2 K (+0.20 %) |
| Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 10.00 | 18,181 | 181,810 | 0 | |
| Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 6.77 | 6,821 | 46,144 | 0 | |
| Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 13.78 | 1,319 | 18,170 | 243,693 | 245 K to 243.7 K (-0.54 %) |
| Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 13.40 | 23,683 | 317,419 | 245,012 | 268.7 K to 245 K (-8.81 %) |
| Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 10.00 | 18,181 | 181,810 | 268,695 | 250.5 K to 268.7 K (+7.26 %) |
| Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 6.77 | 6,821 | 46,144 | 250,514 | 243.7 K to 250.5 K (+2.80 %) |
| Oct 03 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 6.77 | 6,814 | 46,097 | 6,821 | |
| Oct 03 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 3.47 | 18,185 | 63,011 | 0 | |
| Oct 03 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 15.97 | 6,554 | 104,692 | 243,693 | 250.2 K to 243.7 K (-2.62 %) |
| Oct 03 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 15.25 | 18,445 | 281,314 | 250,247 | 268.7 K to 250.2 K (-6.86 %) |
| Oct 03 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 6.77 | 6,814 | 46,097 | 268,692 | 261.9 K to 268.7 K (+2.60 %) |
| Oct 03 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 3.47 | 18,185 | 63,011 | 261,878 | 243.7 K to 261.9 K (+7.46 %) |
| Sep 06 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 3.47 | 24,999 | 86,622 | 18,185 | |
| Sep 06 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 17.99 | 24,999 | 449,680 | 243,693 | 268.7 K to 243.7 K (-9.30 %) |
| Sep 06 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 3.47 | 24,999 | 86,622 | 268,692 | 243.7 K to 268.7 K (+10.26 %) |
| Aug 02 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 3.47 | 24,999 | 86,622 | 43,184 | |
| Aug 02 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 19.55 | 24,999 | 488,768 | 243,693 | 268.7 K to 243.7 K (-9.30 %) |
| Aug 02 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 3.47 | 24,999 | 86,622 | 268,692 | 243.7 K to 268.7 K (+10.26 %) |
| Jul 03 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 3.47 | 24,999 | 86,622 | 68,183 | |
| Jul 03 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 15.48 | 24,999 | 387,002 | 243,693 | 268.7 K to 243.7 K (-9.30 %) |
| Jul 03 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 3.47 | 24,999 | 86,622 | 268,692 | 243.7 K to 268.7 K (+10.26 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 3.47 | 2,272 | 7,872 | 93,182 | |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 4.46 | 22,727 | 101,249 | 0 | |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 18.25 | 4,799 | 87,562 | 243,693 | 248.5 K to 243.7 K (-1.93 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 17.76 | 20,200 | 358,794 | 248,492 | 268.7 K to 248.5 K (-7.52 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 3.47 | 2,272 | 7,872 | 268,692 | 266.4 K to 268.7 K (+0.85 %) |
| Jun 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 4.46 | 22,727 | 101,249 | 266,420 | 243.7 K to 266.4 K (+9.33 %) |
| Feb 21 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 13.55 | 60,000 | 813,000 | 60,000 | |
| Dec 18 2017 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 10.70 | 75,000 | 802,500 | 75,000 | |
| Dec 18 2017 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Grant | A | 9.35 | 472 | 4,413 | 243,208 | 242.7 K to 243.2 K (+0.19 %) |
| Dec 18 2017 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Grant | A | 13.09 | 333 | 4,359 | 242,736 | 242.4 K to 242.7 K (+0.14 %) |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 20.40 | 95,000 | 1,938,000 | 95,000 | |
| Dec 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 3,636 | 5,999 | 0 | |
| Dec 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 23.62 | 500 | 11,810 | 242,403 | 242.9 K to 242.4 K (-0.21 %) |
| Dec 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 22.64 | 3,136 | 71,002 | 242,903 | 246 K to 242.9 K (-1.27 %) |
| Dec 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 3,636 | 5,999 | 246,039 | 242.4 K to 246 K (+1.50 %) |
| Nov 14 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 10,000 | 16,500 | 3,636 | |
| Nov 14 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.18 | 10,000 | 301,839 | 242,200 | 252.2 K to 242.2 K (-3.97 %) |
| Nov 14 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 10,000 | 16,500 | 252,200 | 242.2 K to 252.2 K (+4.13 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 10,000 | 16,500 | 13,636 | |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 31.51 | 6,249 | 196,888 | 242,200 | 248.4 K to 242.2 K (-2.52 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 31.00 | 3,751 | 116,263 | 248,449 | 252.2 K to 248.4 K (-1.49 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 10,000 | 16,500 | 252,200 | 242.2 K to 252.2 K (+4.13 %) |
| Sep 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 10,000 | 16,500 | 23,636 | |
| Sep 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 32.49 | 10,000 | 324,949 | 242,200 | 252.2 K to 242.2 K (-3.97 %) |
| Sep 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 10,000 | 16,500 | 252,200 | 242.2 K to 252.2 K (+4.13 %) |
| Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 10,000 | 16,500 | 33,636 | |
| Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 32.54 | 32 | 1,041 | 242,200 | 242.2 K to 242.2 K (-0.01 %) |
| Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | S | 31.75 | 3,574 | 113,484 | 242,232 | 238.7 K to 242.2 K (+1.50 %) |
| Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.88 | 6,394 | 197,423 | 245,806 | 252.2 K to 245.8 K (-2.54 %) |
| Aug 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 10,000 | 16,500 | 252,200 | 242.2 K to 252.2 K (+4.13 %) |
| Jul 28 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 9,187 | 15,159 | 43,636 | |
| Jul 28 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 813 | 1,341 | 52,823 | |
| Jul 28 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.15 | 9,187 | 277,023 | 242,200 | 251.4 K to 242.2 K (-3.65 %) |
| Jul 28 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 9,187 | 15,159 | 251,387 | 242.2 K to 251.4 K (+3.79 %) |
| Jul 28 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.00 | 813 | 24,392 | 242,200 | 243 K to 242.2 K (-0.33 %) |
| Jul 28 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 813 | 1,341 | 243,013 | 242.2 K to 243 K (+0.34 %) |
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 10,000 | 16,500 | 53,636 | |
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.02 | 10,000 | 300,216 | 242,200 | 252.2 K to 242.2 K (-3.97 %) |
| Jun 03 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 10,000 | 16,500 | 252,200 | 242.2 K to 252.2 K (+4.13 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 9,091 | 15,000 | 63,636 | |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.27 | 24,508 | 31,003 | 0 | |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.27 | 6,401 | 8,097 | 24,508 | |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.04 | 33,599 | 1,009,284 | 242,200 | 275.8 K to 242.2 K (-12.18 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 9,091 | 15,000 | 275,799 | 266.7 K to 275.8 K (+3.41 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.27 | 24,508 | 31,003 | 266,708 | 242.2 K to 266.7 K (+10.12 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.05 | 6,401 | 192,335 | 242,200 | 248.6 K to 242.2 K (-2.57 %) |
| Jun 01 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.27 | 6,401 | 8,097 | 248,601 | 242.2 K to 248.6 K (+2.64 %) |
| Feb 02 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 24.18 | 100,000 | 2,418,000 | 100,000 | |
| Jan 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.27 | 10,000 | 12,650 | 30,909 | |
| Jan 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 32.01 | 3,500 | 112,040 | 241,726 | 245.2 K to 241.7 K (-1.43 %) |
| Jan 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 31.09 | 6,500 | 202,097 | 245,226 | 251.7 K to 245.2 K (-2.58 %) |
| Jan 06 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.27 | 10,000 | 12,650 | 251,726 | 241.7 K to 251.7 K (+4.14 %) |
| Dec 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,550 | 1,752 | 0 | |
| Dec 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 37.24 | 4,550 | 169,452 | 241,726 | 246.3 K to 241.7 K (-1.85 %) |
| Dec 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,550 | 1,752 | 246,276 | 241.7 K to 246.3 K (+1.88 %) |
| Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,545 | 1,750 | 4,550 | |
| Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 34.43 | 2,345 | 80,729 | 241,265 | 243.6 K to 241.3 K (-0.96 %) |
| Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 33.32 | 800 | 26,658 | 243,610 | 244.4 K to 243.6 K (-0.33 %) |
| Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 32.68 | 1,400 | 45,750 | 244,410 | 245.8 K to 244.4 K (-0.57 %) |
| Nov 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,545 | 1,750 | 245,810 | 241.3 K to 245.8 K (+1.88 %) |
| Oct 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,545 | 1,750 | 9,095 | |
| Oct 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 32.88 | 245 | 8,055 | 241,265 | 241.5 K to 241.3 K (-0.10 %) |
| Oct 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 32.22 | 4,300 | 138,547 | 241,510 | 245.8 K to 241.5 K (-1.75 %) |
| Oct 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,545 | 1,750 | 245,810 | 241.3 K to 245.8 K (+1.88 %) |
| Sep 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.99 | 31,818 | 31,500 | 0 | |
| Sep 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.99 | 31,818 | 31,500 | 241,265 | 209.4 K to 241.3 K (+15.19 %) |
| Sep 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,545 | 1,750 | 13,640 | |
| Sep 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 38.94 | 900 | 35,049 | 209,447 | 210.3 K to 209.4 K (-0.43 %) |
| Sep 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 38.41 | 3,645 | 140,010 | 210,347 | 214 K to 210.3 K (-1.70 %) |
| Sep 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,545 | 1,750 | 213,992 | 209.4 K to 214 K (+2.17 %) |
| Aug 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,545 | 1,750 | 18,185 | |
| Aug 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 45.62 | 4,545 | 207,322 | 209,447 | 214 K to 209.4 K (-2.12 %) |
| Aug 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,545 | 1,750 | 213,992 | 209.4 K to 214 K (+2.17 %) |
| Jul 06 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,545 | 1,750 | 22,730 | |
| Jul 06 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 51.13 | 4,545 | 232,381 | 209,447 | 214 K to 209.4 K (-2.12 %) |
| Jul 06 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,545 | 1,750 | 213,992 | 209.4 K to 214 K (+2.17 %) |
| Jun 08 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 25,000 | 9,625 | 27,275 | |
| Jun 08 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 44.18 | 25,000 | 1,104,463 | 209,447 | 234.4 K to 209.4 K (-10.66 %) |
| Jun 08 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 25,000 | 9,625 | 234,447 | 209.4 K to 234.4 K (+11.94 %) |
| Jun 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,545 | 1,750 | 52,275 | |
| Jun 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 41.53 | 4,545 | 188,757 | 209,447 | 214 K to 209.4 K (-2.12 %) |
| Jun 03 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,545 | 1,750 | 213,992 | 209.4 K to 214 K (+2.17 %) |
| May 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,545 | 1,750 | 56,820 | |
| May 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 25.67 | 4,545 | 116,663 | 208,988 | 213.5 K to 209 K (-2.13 %) |
| May 05 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,545 | 1,750 | 213,533 | 209 K to 213.5 K (+2.17 %) |
| Apr 01 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,545 | 1,750 | 61,365 | |
| Apr 01 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 14,500 | 5,583 | 65,910 | |
| Apr 01 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 27.42 | 4,545 | 124,609 | 208,988 | 213.5 K to 209 K (-2.13 %) |
| Apr 01 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,545 | 1,750 | 213,533 | 209 K to 213.5 K (+2.17 %) |
| Apr 01 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 30.20 | 14,500 | 437,909 | 208,988 | 223.5 K to 209 K (-6.49 %) |
| Apr 01 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 14,500 | 5,583 | 223,488 | 209 K to 223.5 K (+6.94 %) |
| Mar 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 4,545 | 1,750 | 80,410 | |
| Mar 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 26.26 | 4,545 | 119,340 | 208,988 | 213.5 K to 209 K (-2.13 %) |
| Mar 04 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 4,545 | 1,750 | 213,533 | 209 K to 213.5 K (+2.17 %) |
| Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 7,145 | 2,751 | 84,955 | |
| Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 0.39 | 7,900 | 3,042 | 92,100 | |
| Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 28.23 | 60,000 | 1,693,800 | 60,000 | |
| Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 28.73 | 7,145 | 205,278 | 208,988 | 216.1 K to 209 K (-3.31 %) |
| Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 7,145 | 2,751 | 216,133 | 209 K to 216.1 K (+3.42 %) |
| Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 27.98 | 7,900 | 221,008 | 208,988 | 216.9 K to 209 K (-3.64 %) |
| Jan 28 2015 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 0.39 | 7,900 | 3,042 | 216,888 | 209 K to 216.9 K (+3.78 %) |
| Jul 10 2014 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 16.90 | 40,000 | 676,000 | 40,000 | |
| May 09 2014 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 10.00 | 18,181 | 181,810 | 18,181 |
Page: 1